1. Home
  2. DRUG vs TTSH Comparison

DRUG vs TTSH Comparison

Compare DRUG & TTSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DRUG
  • TTSH
  • Stock Information
  • Founded
  • DRUG 2019
  • TTSH 1985
  • Country
  • DRUG United States
  • TTSH United States
  • Employees
  • DRUG N/A
  • TTSH N/A
  • Industry
  • DRUG Pharmaceuticals and Biotechnology
  • TTSH Blank Checks
  • Sector
  • DRUG Health Care
  • TTSH Finance
  • Exchange
  • DRUG Nasdaq
  • TTSH Nasdaq
  • Market Cap
  • DRUG 233.2M
  • TTSH 275.5M
  • IPO Year
  • DRUG N/A
  • TTSH N/A
  • Fundamental
  • Price
  • DRUG $27.31
  • TTSH $6.24
  • Analyst Decision
  • DRUG Strong Buy
  • TTSH
  • Analyst Count
  • DRUG 6
  • TTSH 0
  • Target Price
  • DRUG $83.25
  • TTSH N/A
  • AVG Volume (30 Days)
  • DRUG 19.6K
  • TTSH 59.1K
  • Earning Date
  • DRUG 08-13-2025
  • TTSH 08-07-2025
  • Dividend Yield
  • DRUG N/A
  • TTSH N/A
  • EPS Growth
  • DRUG N/A
  • TTSH N/A
  • EPS
  • DRUG N/A
  • TTSH 0.01
  • Revenue
  • DRUG N/A
  • TTSH $343,352,000.00
  • Revenue This Year
  • DRUG N/A
  • TTSH N/A
  • Revenue Next Year
  • DRUG N/A
  • TTSH N/A
  • P/E Ratio
  • DRUG N/A
  • TTSH $342.71
  • Revenue Growth
  • DRUG N/A
  • TTSH N/A
  • 52 Week Low
  • DRUG $0.93
  • TTSH $4.62
  • 52 Week High
  • DRUG $79.02
  • TTSH $7.75
  • Technical
  • Relative Strength Index (RSI)
  • DRUG 41.95
  • TTSH 51.69
  • Support Level
  • DRUG $27.69
  • TTSH $5.89
  • Resistance Level
  • DRUG $28.74
  • TTSH $6.51
  • Average True Range (ATR)
  • DRUG 1.29
  • TTSH 0.23
  • MACD
  • DRUG 0.14
  • TTSH -0.03
  • Stochastic Oscillator
  • DRUG 39.29
  • TTSH 42.65

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

About TTSH Tile Shop Holdings Inc.

Tile Shop Holdings Inc is a specialty retailer of natural stone and man-made tiles, setting and maintenance materials, and related accessories in the United States. It manufactures its setting and maintenance materials, such as thinset, grout, and sealers. The company's primary market is retail sales to consumers, contractors, designers and home builders. Natural stone products include marble, travertine, granite, quartz, sandstone, slate, and onyx tiles. Man-made products include ceramic, porcelain, glass, cement, wood look, metal and luxury vinyl tile.

Share on Social Networks: